Ontology highlight
ABSTRACT:
INSTRUMENT(S): Synapt MS
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Plasma
SUBMITTER: Andreas Hentschel
LAB HEAD: Tobias Ruck
PROVIDER: PXD040786 | Pride | 2023-10-24
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
proc_data_V3.xlsx | Xlsx | |||
schroeter12740.raw.7z | Raw | |||
schroeter12776.raw.7z | Raw | |||
schroeter12963.raw.7z | Raw | |||
schroeter12980.raw.7z | Raw |
Items per page: 1 - 5 of 256 |
JCI insight 20230710 13
Therapeutic strategies targeting complement have revolutionized the treatment of myasthenia gravis (MG). However, a deeper understanding of complement modulation in the human system is required to improve treatment responses and identify off-target effects shaping long-term outcomes. For this reason, we studied a cohort of patients with MG treated with either eculizumab or azathioprine as well as treatment-naive patients using a combined proteomics and metabolomics approach. This strategy valida ...[more]